| 000 | 01929 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250515130123.0 | ||
| 264 | 0 | _c20080916 | |
| 008 | 200809s 0 0 eng d | ||
| 022 | _a1078-0432 | ||
| 024 | 7 |
_a10.1158/1078-0432.CCR-07-4711 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMolenkamp, Barbara G | |
| 245 | 0 | 0 |
_aLocal administration of PF-3512676 CpG-B instigates tumor-specific CD8+ T-cell reactivity in melanoma patients. _h[electronic resource] |
| 260 |
_bClinical cancer research : an official journal of the American Association for Cancer Research _cJul 2008 |
||
| 300 |
_a4532-42 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial | ||
| 650 | 0 | 4 |
_aAntigens, Neoplasm _ximmunology |
| 650 | 0 | 4 |
_aCD8-Positive T-Lymphocytes _ximmunology |
| 650 | 0 | 4 | _aChemotherapy, Adjuvant |
| 650 | 0 | 4 |
_aDendritic Cells _xcytology |
| 650 | 0 | 4 | _aFlow Cytometry |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunotherapy, Active _xmethods |
| 650 | 0 | 4 | _aInjections, Intralesional |
| 650 | 0 | 4 |
_aKiller Cells, Natural _xcytology |
| 650 | 0 | 4 |
_aMelanoma _xdrug therapy |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aNeoadjuvant Therapy |
| 650 | 0 | 4 |
_aOligodeoxyribonucleotides _xadministration & dosage |
| 650 | 0 | 4 | _aSentinel Lymph Node Biopsy |
| 650 | 0 | 4 |
_aSkin Neoplasms _xdrug therapy |
| 700 | 1 | _aSluijter, Berbel J R | |
| 700 | 1 | _avan Leeuwen, Paul A M | |
| 700 | 1 | _aSantegoets, Saskia J A M | |
| 700 | 1 | _aMeijer, Sybren | |
| 700 | 1 | _aWijnands, Pepijn G J T B | |
| 700 | 1 | _aHaanen, John B A G | |
| 700 | 1 | _avan den Eertwegh, Alfons J M | |
| 700 | 1 | _aScheper, Rik J | |
| 700 | 1 | _ade Gruijl, Tanja D | |
| 773 | 0 |
_tClinical cancer research : an official journal of the American Association for Cancer Research _gvol. 14 _gno. 14 _gp. 4532-42 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1158/1078-0432.CCR-07-4711 _zAvailable from publisher's website |
| 999 |
_c18109225 _d18109225 |
||